Table 5.
TEAEs by anatomic location
| Anatomic location | Patients with TEAEs, n (%) | Patients without TEAEs, n (%) | Total patients, n |
|---|---|---|---|
| Heada | 17 (41.5) | 24 (58.5) | 41 |
| Trunkb | 25 (19.2) | 105 (80.8) | 130 |
| Extremitiesc | 5 (15.6) | 27 (84.4) | 32 |
|
| |||
| Comparison | P valued | ||
|
| |||
| Heada versus trunkb | 0.006 | ||
| Heada versus extremitiesc | 0.02 | ||
| Trunkb versus extremitiesc | 0.80 | ||
Notes:
a
Head and neck;
b
Chest, abdomen, and hips;
c
Arms and legs;
d
P values were calculated using Fisher’s exact test.
Abbreviation: TEAE, treatment-emergent adverse event.